Zum Hauptinhalt springen

Hepatitiden

13. September 2023 | Hepatitiden

Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches.

Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches. Brooks R, Wegener M, Freema...

13. September 2023 | Hepatitiden

Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis

Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis Aghaei, Ardavan Mohammad et al. The Lancet Global Health, Volume 11, Issue...

06. Juni 2023 | Hepatitiden

Hepatitis C Infection and Treatment among Injecting Drug Users Attending General Practice: A Systematic Review and Meta-Analysis.

Hepatitis C Infection and Treatment among Injecting Drug Users Attending General Practice: A Systematic Review and Meta-Analysis. Tandan M, Dunlea S, Bury G. Int J Environ Res Public Health. 2023 Apr 18;20(8):5569. doi: 10.3390/ijerp...

06. Juni 2023 | Hepatitiden

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia.

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia. Aung PTZ, Spelman T, Wilkinson AL, Dietze PM, Stoové MA, Hellard ME. Epidemiol Infect. 2023 May 9;151:e84. doi: 10.1017/S0950268823000675...

06. Juni 2023 | Hepatitiden

Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs - a scoping review of the qualitative evidence.

Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs - a scoping review of the qualitative evidence. Balsom CR, Farrell A, Kelly DV. BMC Public Health. 2023 Jun 1;23(1):1038. doi: 10.1186/s12889...

06. Juni 2023 | Hepatitiden

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study.

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study. Malme KB, Ulstein K, Finbråten AK, Wüsthoff LEC, Kielland KB, Hauge J, Dalgard O, Midgard H. Int J Drug Policy. 2023 Jun;116:104044. ...

29. Mai 2023 | Hepatitiden

DAH. Heptatitis C: Behandlung in Haft

DAH. Heptatitis C: Behandlung in Haft Informationen für Menschen in Haft zu Übertragung, Verlauf und Diagnose der Hepatitis C. Schwerpunkt bilden Erläuterungen zur Behandlung sowie Hinweise, was im Fall einer Ablehnung der Behandlung zu tun ist; ...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten